We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

105 hedge funds and large institutions have $150M invested in Perspective Therapeutics in 2025 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

12,450% more call options, than puts

Call options by funds: $251K | Put options by funds: $2K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

8% more funds holding

Funds holding: 97 → 105 (+8)

1.67% more ownership

Funds ownership: 57.23% → 58.91% (+1.7%)

7% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 30

3% more capital invested

Capital invested by funds: $146M → $150M (+$3.71M)

Holders
105
Holders Change
+8
Holders Change %
+8.25%
% of All Funds
1.38%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
16
Increased
32
Reduced
30
Closed
8
Calls
$251K
Puts
$2K
Net Calls
+$249K
Net Calls Change
-$131K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$4.15M
2
APM
Avidity Partners Management
Texas
+$4.14M
3
VC
Vestor Capital
Illinois
+$3.54M
4
Bank of America
Bank of America
North Carolina
+$1.67M
5
Walleye Capital
Walleye Capital
New York
+$1.31M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.98M
2
N
Nuveen
North Carolina
-$3.6M
3
AAA
Affinity Asset Advisors
New York
-$2.73M
4
Marshall Wace
Marshall Wace
United Kingdom
-$1.79M
5
VCIM
Velan Capital Investment Management
Georgia
-$1.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
AAA
26
Affinity Asset Advisors
New York
$1.03M -$2.73M -750,000 -71%
PIC
27
Portland Investment Counsel
Ontario, Canada
$858K – – –
Wellington Management Group
28
Wellington Management Group
Massachusetts
$709K +$753K +206,632 New
Federated Hermes
29
Federated Hermes
Pennsylvania
$680K +$11.3K +3,111 +2%
Goldman Sachs
30
Goldman Sachs
New York
$678K -$271K -74,388 -27%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$649K +$35.5K +9,738 +5%
SL
32
Sentinus LLC
Illinois
$565K +$600K +164,711 New
SNWA
33
Siligmueller & Norvid Wealth Advisors
Illinois
$565K +$600K +164,711 New
Citadel Advisors
34
Citadel Advisors
Florida
$551K +$424K +116,201 +261%
Citigroup
35
Citigroup
New York
$430K +$105K +28,758 +30%
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$356K -$506K -138,874 -57%
BCM
37
Bridgeway Capital Management
Texas
$329K -$54.7K -15,000 -14%
TMWM
38
Taylor & Morgan Wealth Management
Michigan
$312K -$10.9K -3,000 -3%
Mariner
39
Mariner
Kansas
$295K +$78.9K +21,653 +34%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$291K +$5.67K +1,555 +2%
Barclays
41
Barclays
United Kingdom
$288K -$70.8K -19,426 -19%
AllianceBernstein
42
AllianceBernstein
Tennessee
$286K – – –
TWM
43
Trueblood Wealth Management
Ohio
$237K – – –
Qube Research & Technologies (QRT)
44
Qube Research & Technologies (QRT)
United Kingdom
$237K -$93.8K -25,734 -27%
XT
45
XTX Topco
Cayman Islands
$207K +$220K +60,402 New
CSS
46
Cubist Systematic Strategies
Connecticut
$194K +$159K +43,674 +335%
CFG
47
Citizens Financial Group
Rhode Island
$182K – – –
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$176K -$237K -65,042 -56%
Deutsche Bank
49
Deutsche Bank
Germany
$175K +$25.8K +7,066 +16%
Wells Fargo
50
Wells Fargo
California
$157K +$27.2K +7,452 +19%
1
2
3 4 5

CATX Hedge Fund Activity: Q3 2025 in Review

105 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q3 2025, worth a combined $150M — up 2.5% from $146M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new CATX positions and 8 closed out — a net gain of 8 holders — while 32 added to existing stakes and 30 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $4.15M. The largest seller was Fidelity Investments, cutting an estimated $3.98M.

  • 105 institutional investors held Perspective Therapeutics (CATX) as of Q3 2025, up from 97 in Q2 2025.
  • Funds reported $150M of Perspective Therapeutics stock for Q3 2025, up 2.5% quarter-over-quarter.
  • 16 funds opened new Perspective Therapeutics positions in Q3 2025 and 8 closed out, a net change of +8 holders.
  • The largest Perspective Therapeutics buyer in Q3 2025 was Morgan Stanley, an estimated $4.15M added.
  • The largest Perspective Therapeutics seller in Q3 2025 was Fidelity Investments, an estimated $3.98M sold.

Based on aggregated 13F filings for Q3 2025.